Castle Biosciences to Release Third Quarter 2025 Financial Results and Host Conference Call on Monday, Nov. 3, 2025

Core Insights - Castle Biosciences, Inc. will release its financial results for Q3 and the nine months ended September 30, 2025, on November 3, 2025, after market close [1] - A conference call and webcast will be held on the same day at 4:30 p.m. Eastern time to discuss the financial results [1] Company Overview - Castle Biosciences is a leading diagnostics company focused on improving health through innovative tests that guide patient care [4] - The company aims to transform disease management by prioritizing patients, clinicians, employees, and investors [4] Product Portfolio - Castle's current portfolio includes tests for skin cancers, Barrett's esophagus, and uveal melanoma [5] - The company is also engaged in R&D for tests addressing high clinical needs, including a test for guiding systemic therapy selection for patients with moderate-to-severe atopic dermatitis [5] Conference Call Details - A live webcast of the conference call can be accessed through the company's Investor Relations page [2] - For phone access, dial 1 833 470 1428 from the U.S. with access code 735311, and international numbers are available [3] - A brief Q&A session will follow the management commentary during the call [3]